TABLE 2.
Operative characteristics and pathology (n = 65)
| Operative characteristics and pathology | |
|---|---|
| Operative time (min) (mean ± SD) (n = 60) | 438.4 (± 110.7) |
| Estimated blood loss (ml) (median, IQR) (n = 51) |
600 (400–1,500) |
| Simplified peritoneal cancer index (SPCI) (median, IQR) |
12 (8–16) |
| HIPEC (n, %) | 65 (100) |
| HIPEC drug (n, %) | |
| Mitomycin C | 61 (93.8) |
| Cisplatin | 4 (6.2) |
| Completeness of cytoreduction (n, %) | |
| CC-0 | 35 (53.8) |
| CC-1 | 21 (32.3) |
| CC-2 | 5 (7.7) |
| CC-3 | 4 (6.2) |
| Surgical resection (n, %) | |
| Lysis of adhesions | 31 (47.7) |
| Omentectomy | 60 (92.3) |
| Splenectomy | 31 (47.7) |
| Diaphragmatic stripping or resection | 27 (41.5) |
| Hepatectomy or RFA | 6 (9.2) |
| Cholecystectomy | 12 (18.5) |
| Low anterior resection | 6 (9.2) |
| Total abdominal colectomy | 1 (1.5) |
| Small bowel resection | 6 (9.2) |
| Partial gastrectomy | 2 (3.1) |
| Ureterolysis | 11 (16.9) |
| Hysterectomy | 1 (1.5) |
| Ostomy | 6 (9.2) |
| No. of anastamoses (n, %) | |
| None | 46 (70.8) |
| 1 anastamosis | 14 (21.5) |
| 2 anastamoses | 4 (6.2) |
| 3 anastamoses | 1 (1.5) |
| Histologic classification (n, %) (n = 63) | |
| Epithelioid | 51 (81) |
| Sarcomatous | 3 (4.8) |
| Biphasic/mixed | 5 (7.9) |
| Well-differentiated papillary | 2 (3.2) |
| Multicystic | 2 (3.2) |
| Tumor grade (n, %) (n = 41) | |
| Low grade | 20 (48.8) |
| High grade | 21 (51.2) |
| Positive lymph node status (n, %) (n = 61) | 5 (8.2) |
HIPEC hyperthermic intraperitoneal chemoperfusion